Cedars-Sinai scientists have created a new experimental drug called TY1 that helps the body repair damaged DNA and restore ...

RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...

A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...

Scientists discovered ribose — in addition to “all five nucleobases used to construct both DNA and RNA” — on asteroid Bennu, ...

Scientists have sequenced RNA from a nearly 40,000-year-old woolly mammoth leg, the oldest ancient RNA ever recovered. These ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

In a study published in Science Translational Medicine, researchers at Cedars-Sinai report that an experimental drug called TY1 helped damaged hearts heal in laboratory animals. It did not thin blood ...

A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...

Researchers have used cryo-EM and computational tools to visualize ribozyme assembly, shedding light on life's most versatile ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

We have long struggled to determine how the first living organisms on Earth came together. Now, surprising evidence hints ...